Jazz Pharmaceuticals PLC (JAZZ)
109.51
+2.08
(+1.94%)
USD |
NASDAQ |
Apr 26, 16:00
109.51
0.00 (0.00%)
After-Hours: 16:27
Jazz Pharmaceuticals Cash from Financing (Quarterly): -100.31M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.31M |
| September 30, 2023 | -78.49M |
| June 30, 2023 | -96.67M |
| March 31, 2023 | -29.79M |
| December 31, 2022 | 19.60M |
| September 30, 2022 | -289.05M |
| June 30, 2022 | 10.78M |
| March 31, 2022 | -270.81M |
| December 31, 2021 | -246.61M |
| September 30, 2021 | -465.18M |
| June 30, 2021 | 4.664B |
| March 31, 2021 | 18.28M |
| December 31, 2020 | 55.88M |
| September 30, 2020 | -22.66M |
| June 30, 2020 | 642.53M |
| March 31, 2020 | -147.68M |
| December 31, 2019 | -87.78M |
| September 30, 2019 | -19.46M |
| June 30, 2019 | -56.15M |
| March 31, 2019 | -130.35M |
| December 31, 2018 | -446.46M |
| September 30, 2018 | -13.97M |
| June 30, 2018 | 28.87M |
| March 31, 2018 | -47.58M |
| December 31, 2017 | -39.98M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.03M |
| June 30, 2017 | -214.48M |
| March 31, 2017 | -181.67M |
| December 31, 2016 | -172.04M |
| September 30, 2016 | 895.22M |
| June 30, 2016 | -29.74M |
| March 31, 2016 | -152.46M |
| December 31, 2015 | -123.86M |
| September 30, 2015 | -94.42M |
| June 30, 2015 | 7.223M |
| March 31, 2015 | -3.261M |
| December 31, 2014 | -10.44M |
| September 30, 2014 | 263.27M |
| June 30, 2014 | -39.46M |
| March 31, 2014 | 497.66M |
| December 31, 2013 | -28.72M |
| September 30, 2013 | -45.72M |
| June 30, 2013 | 47.46M |
| March 31, 2013 | 3.133M |
| December 31, 2012 | 3.59M |
| September 30, 2012 | -5.488M |
| June 30, 2012 | 468.65M |
| March 31, 2012 | -18.22M |
| December 31, 2011 | 2.801M |
| September 30, 2011 | -33.61M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-465.18M
Minimum
Sep 2021
4.664B
Maximum
Jun 2021
184.23M
Average
-56.15M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Alkermes PLC | -276.50M |
| Endo International PLC | -149.76M |
| Medtronic PLC | -1.50B |
| Perrigo Co PLC | -44.60M |
| Iterum Therapeutics PLC | 0.589M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 167.34M |
| Cash from Investing (Quarterly) | 101.80M |
| Free Cash Flow | 1.049B |
| Free Cash Flow Per Share (Quarterly) | 1.999 |
| Free Cash Flow to Equity (Quarterly) | 141.56M |
| Free Cash Flow to Firm (Quarterly) | 247.38M |
| Free Cash Flow Yield | 13.29% |